323 related articles for article (PubMed ID: 32741537)
1. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
[TBL] [Abstract][Full Text] [Related]
2. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice.
Matsumoto S; Matsumoto M; Umemori K; Ozeki Y; Furugen M; Tatsuo T; Hirayama Y; Yamamoto S; Yamada T; Kobayashi K
J Immunol; 2005 Jul; 175(1):441-9. PubMed ID: 15972678
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
[TBL] [Abstract][Full Text] [Related]
4. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
5. Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
Todoroff J; Lemaire MM; Fillee C; Jurion F; Renauld JC; Huygen K; Vanbever R
PLoS One; 2013; 8(5):e63344. PubMed ID: 23675482
[TBL] [Abstract][Full Text] [Related]
6. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.
Grover A; Troudt J; Foster C; Basaraba R; Izzo A
Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616
[TBL] [Abstract][Full Text] [Related]
7. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
[TBL] [Abstract][Full Text] [Related]
9. Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.
Vorkas CK; Levy O; Skular M; Li K; Aubé J; Glickman MS
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077620
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.
da Fonseca DM; Silva CL; Wowk PF; Paula MO; Ramos SG; Horn C; Marchal G; Bonato VL
Infect Immun; 2009 Dec; 77(12):5311-21. PubMed ID: 19752029
[TBL] [Abstract][Full Text] [Related]
11. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
Silva-Sánchez A; Meza-Pérez S; Flores-Langarica A; Donis-Maturano L; Estrada-García I; Calderón-Amador J; Hernández-Pando R; Idoyaga J; Steinman RM; Flores-Romo L
PLoS One; 2015; 10(4):e0124828. PubMed ID: 25915045
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.
Juffermans NP; Leemans JC; Florquin S; Verbon A; Kolk AH; Speelman P; van Deventer SJ; van der Poll T
Infect Immun; 2002 Jan; 70(1):147-52. PubMed ID: 11748176
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
14. Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery.
Todoroff J; Ucakar B; Inglese M; Vandermarliere S; Fillee C; Renauld JC; Huygen K; Vanbever R
Eur J Pharm Biopharm; 2013 May; 84(1):40-8. PubMed ID: 23238272
[TBL] [Abstract][Full Text] [Related]
15. Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.
Giri PK; Verma I; Khuller GK
Immunotherapy; 2009 Jan; 1(1):31-7. PubMed ID: 20635971
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.
Simmons DP; Canaday DH; Liu Y; Li Q; Huang A; Boom WH; Harding CV
J Immunol; 2010 Aug; 185(4):2405-15. PubMed ID: 20660347
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.
Esparza-Gonzalez SC; Troy AR; Izzo AA
Clin Vaccine Immunol; 2014 Apr; 21(4):501-8. PubMed ID: 24477855
[TBL] [Abstract][Full Text] [Related]
18. [A study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice].
Ren T; Liang YJ; Cai YY; Li CY; Mei J; Yuan ZH; Tao MF; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):46-50. PubMed ID: 18366907
[TBL] [Abstract][Full Text] [Related]
19. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
Front Immunol; 2020; 11():575504. PubMed ID: 33117374
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
